

Discontinued (Oct 2022)- Master of Hospital Management
- A NAAC accredited
- State University
- Estd. 2008
Discontinued (Oct 2022)- Master of Hospital Management at DPSRU Overview
Duration | 2 years |
Course Level | PG Degree |
Mode of Course | Full Time |
Official Website | Go to Website |
Type of University | State |
Discontinued (Oct 2022)- Master of Hospital Management at DPSRU Frequently Asked Questions
DSPRU shortlists candidates based on their merit and performance in the accepted exam. The university considers merit in the last qualifying exam for UG courses. For admission to PG courses, CUET-PG score is considered. DPSRU accepts GPAT for MPharm programme. Selected candidates are required to confirm their seat by paying the course fee.
The key highlights of DPSRU placements 2023 are presented below:
Course | Average Package (2023) | Highest Package (2023) |
|---|---|---|
INR 5.67 LPA | INR 15 LPA | |
INR 6.84 LPA | INR 15 LPA |
Further, as per the NIRF report 2024, the key highlights of BPharm and MPharm placements over the past three years are presented below:
Particulars | BPharm Placement Statistics (2021) | BPharm Placement Statistics (2022) | BPharm Placement Statistics (2023) |
|---|---|---|---|
Median package | INR 4.2 LPA | INR 4.5 LPA | INR 3.66 LPA |
Total students | 125 | 133 | 152 |
Students placed | 16 | 16 | 15 |
Students opted for higher studies | 99 | 104 | 94 |
Particulars | MPharm Placement Statistics (2021) | MPharm Placement Statistics (2022) | MPharm Placement Statistics (2023) |
Median package | INR 5.6 LPA | INR 6.52 LPA | INR 5.65 LPA |
Total students | 100 | 113 | 118 |
Students placed | 88 | 90 | 50 |
Students opted for higher studies | 5 | 10 | 8 |
Candidates need to complete a minimum of Class 12 to apply for any of the UG courses of DPSRU. The minimum aggregate required is 55% for most of the UG programmes. There is 5% relaxation in the aggregate for SC/ ST/ OBC/ PwD candidates. Since admission to UG courses is based on merit in the last qualifying exam, candidates must fulfil the course-specific eligibility.
Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR) offers B.Pharm, D.Pharm, M.Pharm, and Ph.D. programs. Applicants who hold a Bachelor's in Pharmacy with at least 55% aggregate marks are eligible to apply. Admission to both D.Pharm and B.Pharm will be based on the merit of the qualifying examination.
- For Non-Delhi general category, the cutoff for admission to DIPSAR was 95.67 percent for M.Pharma for the 2021-2022 academic year.
- To get admission in M.Pharma in Clinical Research at DPSRU, candidates should be GPAT qualified with a good rank and should have scored a minimum of 60% aggregate marks.
It is recommended to check the official website of DPSRU or DIPSAR for the latest information on the minimum marks required to get a seat at Delhi Pharmaceutical Sciences and Research University.
Discontinued (Oct 2022)- Master of Hospital Management at DPSRU Placements
Discontinued (Oct 2022)- Master of Hospital Management at DPSRU Entry Requirements
Explore Courses offered by DPSRU
Get best suited colleges for you in real-time
Tell us about your city, course, budget & more
Discover best colleges that meet all your needs
Compare Courses From Similar Colleges
Similar courses in the same city
Discontinued (Oct 2022)- Master of Hospital Management at DPSRU Students also asked
Delhi Pharmaceutical Sciences and Research University admissions are currently open for 2025 session. The applications are closed for now. Aspirants are offered admission in the university based on their scores in entrance exam or qualifying examination. The mode of application is online for all the courses offered at DPSRU.
Delhi Pharmaceutical Sciences and Research University considers course-specific eligibility for admission. Aspirants will also need to appear for entrance exam for PG courses. Below is DPSRU eligibility criteria for top courses:
| Course | Common Eligibility |
|---|---|
| BPharm | Class 12 with PCM/ PCB with at least 55% aggregate (50% aggregate for SC/ ST/ OBC/ PwD) |
| MBA | Bachelor's degree in relevant disciplines with at least 55% aggregate |
| DPharm | Class 12 with PCM/ PCB with at least 55% aggregate (50% aggregate for SC/ ST/ OBC/ PwD) |
| MPT | BPT with at least 55% aggregate (50% aggregate for SC/ ST/ PBC/ PwD) |
| BMLT | Class 12 with PCM/ PCB with at least 55% aggregate (50% aggregate for SC/ ST/ OBC/ PwD) |
The Delhi Pharmaceutical Sciences and Research University is a 100% grant-in-aid State Government University. DPSRU Delhi is famous for being the 1st Pharmaceutical University in India and 3rd in the world. Moreover, DPSRU Delhi has been ranked as 16th in the Pharmacy Category by the National Institutional Ranking Framework (NIRF) and ranked as A Grade by the NAAC.
CUET PG Result released will tentatively be release in May, 2026.
DPSRU invites applications for Merit-cum-Means scholarship from economically weaker and meritorious students from minority communities (Buddhist, Christian, Jain, Muslim, Zoroastrian (Parsi) and Sikh. Candidates need to apply for scholarship on the National Scholarship Portal.
Student Forum
Discontinued (Oct 2022)- Master of Hospital Management at DPSRU News & Updates




Discontinued (Oct 2022)- Master of Hospital Management at DPSRU Contact Information
Useful Links
Know more about DPSRU
- All About DPSRU
- Courses 2026
- Fees 2026
- Reviews on Placements, Faculty & Facilities
- Admission 2026 - Cutoffs, Eligibility & Dates
- Placement - Highest & Average Salary Package
- Cut off & Merit List 2026
- DPSRU Rankings
- Gallery 2026
- Infrastructure Details & Reviews
- DPSRU Faculty
- Compare DPSRU
- DPSRU Q&A
- Scholarships
- DPSRU News & Articles
Know more about Programs
- Medical Courses
- Public Health & Management
- Hospital Management Course
- Perfusion Technology
- Diabetology
- Dialysis Technology
- BSc Operation Theatre Technology
- BSc in Perfusion Technology
- BSc Physician Assistant
- Physician Assistant
- BSc in Respiratory Care Technology
- Pediatrics Courses
- Echo Cardiology & Cardiac Technology
- Clinical Data Management
- Pharmacovigilance